Trials / Completed
CompletedNCT04080921
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis
The Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis at Vinmec International Hospital
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology · Academic / Other
- Sex
- All
- Age
- 2 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of autologous bone marrow-derived mononuclear cell transplantation in-patient with neurological sequelae due to encephalitis or meningitis
Detailed description
The purpose of this study is to evaluate the safety and effectiveness of autologous bone marrow-derived mononuclear cell in 22 patients with neurological sequelae due to encephalitis or meningitis at Vinmec International Hospital, Hanoi, Vietnam
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Stem cell transplantation | Transplantation of Autologous Bone Marrow Mononuclear Cells |
Timeline
- Start date
- 2014-06-16
- Primary completion
- 2019-06-30
- Completion
- 2019-08-30
- First posted
- 2019-09-06
- Last updated
- 2024-06-06
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT04080921. Inclusion in this directory is not an endorsement.